Abstract

MO-0470 IMPT reduces esophageal and pulmonary toxicity compared to VMAT in stage II-IV NSCLC patients

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call